Types of stem cell transplants
A stem cell transplant (also known as a bone marrow transplant) is a procedure in which defective or cancerous bone marrow is replaced with new, healthy bone marrow cells. A stem cell transplant may be used to treat leukemia and lymphoma, cancers that affect the blood and lymphatic system. Additionally, transplants are used to treat hereditary blood disorders, such as sickle cell anemia, and autoimmune diseases, such as multiple sclerosis. They also can help patients recover from or better tolerate cancer treatment.
What is a stem cell?
Stem cells refer to specialized cells that can mature into different kinds of cells, depending on what your body needs. They are located in various places throughout your body, including your bone marrow. Bone marrow contains hematopoietic stem cells that constantly divide to produce all the different kinds of blood cells. Young hematopoietic stem cells can mature into any of the following cell types:
- Red blood cells, which carry oxygen
- Platelets, which help the blood clot
- White blood cells, which help fight infection
Any disease or condition that impacts the ability of your bone marrow to produce new blood cells can have serious health consequences. Bone marrow transplantation may be an effective treatment for such conditions.
How do stem cell transplants work?
In general, the first step to a successful stem cell transplant is harvesting healthy bone marrow, either from the patient or from a donor. This involves putting the patient or donor under general anesthesia and using a large needle to remove bone marrow from their pelvis. The bone marrow can then be frozen and stored. When it is ready for use, it is thawed and injected into a patient, much like a blood transfusion. The healthy stem cells will travel to bone marrow sites and start making blood cells.
There are two types of stem cell transplantation:
Autologous stem cell transplant
In an autologous stem cell or bone marrow transplant, healthy cells are harvested from the bone marrow of a patient. The harvested bone marrow is frozen and stored until it is ready for use. In the meantime, the patient undergoes a 'conditioning regimen' to prepare their body for the transplant. In this regimen, they may receive high dose chemotherapy r radiation therapy. These treatments destroy cancer cells, but they also kill bone marrow cells. This is where the transplant comes in. The patient is injected with their own stored blood stem cells. These cells 'take' to the body and restore its ability to produce blood cells.
Autologous transplantation is most often used to treat diseases like lymphoma and multiple myeloma. Because autologous transplants use the cells of a patient, they have little to no risk of rejection or graft-versus-host disease (GVHD). This makes it safer than allogeneic transplants.
Allogeneic stem cell transplant
An allogeneic bone marrow or stem cell transplant uses donor stem cells to treat blood cancers that affect the bone marrow, like leukemia. The cell transplants come from a donor whose tissue most closely matches that patient. The donor cells are injected after the patient has undergone chemotherapy. But beyond restoring the blood-producing ability of the body, allogeneic stem cell transplantation can help fight cancer directly. The donated cells generate a new immune response, meaning they find and kill cancer cells, sometimes better than the original immune cells of the patient. This is called the graft-versus-cancer effect, and it can help fight cancer. Unfortunately, allogeneic stem cells come with an increased risk of rejection or GVHD.
Finding stem cell donors
For allogeneic transplants to work, a patient needs to be matched with a donor whose human leukocyte antigen (HLA) proteins closely match theirs. HLA proteins dot your cells' surface and help your body distinguish normal cells from foreign cells. If the HLA proteins of a donor are a poor match to a patient, there is an increased risk of GVHD.
HLA typing is the process by which stem cell transplant patients are matched with eligible donors. In HLA typing, a blood sample from a patient is compared with samples from family members or a donor registry. The best match is usually a first-degree relative (children, siblings, or parents). However, about 75% of patients do not have suitable donors in their family and require cells from a matched unrelated donor (MUD). Stem cell donors are located through registries such as the National Marrow Donor Program. It can sometimes take several weeks or longer to find a suitable donor.
If a suitable donor cannot be found, there are other options, including:
- Haploidentical transplants: This type of transplant uses bone marrow from a first-degree relative (such as a parent, sibling, or child) that is a half-match for a patient. Haploidentical transplants have become safer over time, and they have the benefit of decreased wait time.
- Umbilical cord blood transplant: The umbilical cord connects a fetus to the placenta during pregnancy. It contains hematopoietic stem cells. Once the baby is born, the umbilical cord is no longer needed. Its stem cells can be harvested and saved in a cord blood bank for use in cancer treatments. The MD Anderson Cord Blood Bank actively seeks donations of umbilical cords.
Stem cell transplant side effects
Because the immune system of a patient is wiped out before a stem cell transplant, it takes about six months to a year for the immune system to recover and start producing healthy new blood cells. Transplant patients are at increased risk for infections during this time and must take precautions. This may include using medications like antibiotics.
Other side effects include:
- Graft versus host disease (GVHD): This condition occurs when the body’s immune cells attack cells from the donor, or when the donor cells attack your cells. GVHD can occur right after the transplant or more than a year later.
- Increased risk of bleeding
- Anemia: Some patients may require a blood transfusion to treat persistent low red blood cell counts.
- Mouth sores
Following a transplant, you will need to regularly follow up with your doctor so they can monitor how your body and immune system are responding to the transplant. If you develop any of the above symptoms or have any concerns, tell your doctor right away to catch any concerns early.
Stem Cell Transplantation and Cellular Therapy Center
Appointments at MD Anderson
Our Health Information Specialists can answer your questions about MD Anderson and help you schedule an appointment.
- To speak with a Health Information Specialist, call 877-632-6789.
Stem Cells, Clinical Trials Lead to Remission
When Sandra Hurley was diagnosed with CLL in 1997, an Ohio-based oncologist gave her just two to four years to live. “After I went through the shock…I just thought, ‘This is unacceptable.’”
Two Stem Cell Transplants Benefit Myeloma Patient
Don Kendall was able to complete virtually all his treatment as an outpatient. Almost two years later he is managing his cancer much like a chronic condition such as diabetes.
Chemistry professor Bindu Chakravarty rarely missed a day teaching at Houston Community College. So when she called in sick one morning, it was with good reason.
Stem Cell Patient Finds Hope After Third Diagnosis
“The drugs were not new, but the combination was. So when I was given the option for a clinical trial, I took it.”
Understanding Stem Cell Transplants
Borje S. Andersson, M.D., Ph.D., explains the different types of stem cell transplants, what makes a good donor match, and the latest stem cell transplant research at MD Anderson.
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.